A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LFX453
Clinical trial NCT02052687 · COMPLETED
Trial details
- NCT number
- NCT02052687
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-01
- Primary completion
- 2014-06-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.